2m 2m 2m 2m 2m 2m 2m
CYTEK BIOSCI (CTKB)
NASDAQ
$5.88+$0.07 (+1.12%)
Price as of Oct 02, 2026 4:10 PM EDT- $755.2MMarket Cap
- 59.18%1-Year Change
- Medical DevicesIndustry
CYTEK BIOSCI (CTKB)
$5.88+$0.07 (+1.12%)
CTKB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.81 | ||
Change | -$0.15 (-2.52%) | ||
Open | $5.96 | ||
High | $5.97 | ||
Low | $5.75 | ||
Previous Close | $5.96 | ||
Volume | 1,571,621 | ||
30-Day Average Volume | 1,332,875 | ||
1-Week Change | 1.40% | ||
1-Month Change | 25.76% | ||
1-Year Change | 59.18% | ||
3-Year Change | 5.25% | ||
5-Year Change | -72.83% | ||
Fundamentals | |||
Shares Outstanding | 130.0M | ||
Total Assets | $446.9M | ||
Market Cap | $755.2M | ||
Enterprise Value | $683.4M | ||
Period: QTR TTM FY | |||
Revenue | $32.6M | ||
Net Income | -$12.2M | ||
Free Cash Flow | -$849,000.00 | ||
EBIT | -$11.6M | ||
EBITDA | -$9.6M | ||
Net Working Capital | $293.6M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -71 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -890 | ||
Price/Operating Cash Flow | 552 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue